MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $48,000 | -9.4% | 743 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $53,000 | -27.4% | 743 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $73,000 | +15.9% | 743 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $63,000 | +6.8% | 743 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $59,000 | -18.1% | 743 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $72,000 | -17.2% | 743 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $87,000 | +4.8% | 743 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $83,000 | -5.7% | 743 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $88,000 | +4.8% | 743 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $84,000 | +68.0% | 743 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $50,000 | -26.5% | 743 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $68,000 | +6.2% | 743 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $64,000 | -17.9% | 743 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $78,000 | -16.1% | 743 | 0.0% | 0.01% | -16.7% |
| Q1 2019 | $93,000 | +10.7% | 743 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $84,000 | -57.6% | 743 | -19.7% | 0.01% | -50.0% |
| Q3 2018 | $198,000 | +13.1% | 925 | +48.0% | 0.01% | +9.1% |
| Q2 2018 | $175,000 | -4.9% | 625 | -68.8% | 0.01% | 0.0% |
| Q4 2017 | $184,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |